المؤلفون: Weickhardt A; Olivia Newton-John Cancer and Wellness Centre, Austin Hospital, Melbourne, Australia. Electronic address: andrew.weickhardt@austin.org.au., Foroudi F; Olivia Newton-John Cancer and Wellness Centre, Austin Hospital, Melbourne, Australia., Lawrentschuk N; Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, Australia., Xie J; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, Australia., Sidhom M; Liverpool Hospital, Sydney, Australia., Pal A; Liverpool Hospital, Sydney, Australia., Grimison P; Chris O'Brien Lifehouse, Sydney, Australia., Zhang A; Chris O'Brien Lifehouse, Sydney, Australia., Ng S; Sir Charles Gairdner Hospital, Perth, Australia., Tang C; Sir Charles Gairdner Hospital, Perth, Australia., Hovey E; Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Sydney, Australia., Chen C; Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Sydney, Australia., Hruby G; Royal North Shore Hospital, Sydney, Australia., Guminski A; Royal North Shore Hospital, Sydney, Australia., McJannett M; Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Sydney, Australia., Conduit C; Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, Australia; Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Sydney, Australia., Tran B; Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, Australia., Davis ID; Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Sydney, Australia; Monash University, Melbourne, Australia; Eastern Health, Melbourne, Australia., Hayne D; Fiona Stanley Hospital, Perth, Australia.

المصدر: European urology oncology [Eur Urol Oncol] 2024 Jun; Vol. 7 (3), pp. 469-477. Date of Electronic Publication: 2023 Oct 07.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/therapy , Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/pathology , Antibodies, Monoclonal, Humanized*/therapeutic use , Chemoradiotherapy*/methods , Chemoradiotherapy*/adverse effects , Neoplasm Invasiveness*, Humans ; Male ; Female ; Aged ; Middle Aged ; Treatment Outcome ; Antineoplastic Agents, Immunological/therapeutic use ; Feasibility Studies ; Aged, 80 and over ; Cisplatin/therapeutic use

المؤلفون: Marx G; San Clinical Trial Unit, Sydney Adventist Hospital, Integrated Cancer Centre, Wahroonga, Australia.; ANU Medical School, Australian National University, Canberra, Australia., Chowdhury S; Guy's and St Thomas' Hospitals, London, UK., Krieger L; Genesis Care, St Leonards, Sydney, Australia., Hovey E; Department of Medical Oncology, Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Randwick, Australia.; University of New South Wales, Sydney, Australia., Shapiro J; Department of Medical Oncology, Cabrini Haematology and Oncology Centre, Malvern, Australia., Tran B; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Tan TH; Department of Medical Oncology, Royal Adelaide Hospital, Adelaide and Icon Cancer Centre, Adelaide, Australia., Ng S; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Australia., Woo HH; San Prostate Centre of Excellence, Sydney Adventist Hospital, Wahroonga, Australia.; Department of Uro-Oncology, Chris O'Brien Lifehouse, Camperdown, Australia.; ANU College of Health and Medicine, Australian National University, Canberra, Australia.

المصدر: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2024 Aug; Vol. 20 (4), pp. 435-443. Date of Electronic Publication: 2024 Apr 19.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Blackwell Pub. Asia Country of Publication: Australia NLM ID: 101241430 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1743-7563 (Electronic) Linking ISSN: 17437555 NLM ISO Abbreviation: Asia Pac J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Thiohydantoins*/administration & dosage , Thiohydantoins*/therapeutic use , Thiohydantoins*/adverse effects , Prostatic Neoplasms, Castration-Resistant*/drug therapy, Humans ; Male ; Australia ; Androgen Antagonists/administration & dosage ; Androgen Antagonists/adverse effects ; Androgen Antagonists/therapeutic use ; Practice Guidelines as Topic

المؤلفون: Conduit C; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia., Davis ID; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Eastern Health Clinical School, Monash University, Box Hill, VIC, Australia.; Eastern Health, Melbourne, VIC, Australia., Goh JC; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Royal Brisbane and Women's Hospital, Herston, QLD, Australia., Kichenadasse G; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Flinders Centre for Innovation in Cancer, Flinders Medical Centre, Bedford Park, SA, Australia., Gurney H; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Macquarie University, Sydney, NSW, Australia., Harris CA; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; St George Hospital Cancer Care Centre, Kogarah, NSW, Australia.; University of NSW South Wales, Sydney, NSW, Australia., Pook D; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Monash Health, Melbourne, VIC, Australia., Krieger L; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; GenesisCare North Shore, St Leonards, NSW, Australia., Parnis F; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Adelaide Cancer Centre, Kurralta Park, SA, Australia., Underhill C; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Border Medical Oncology Research Unit, Albury Wodonga Regional Cancer Centre, East Albury, NSW, Australia.; Rural Medical School, Albury Campus, University of New South Wales, Albury-Wodonga, NSW, Australia., Adams D; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Macarthur Cancer Therapy Centre, Campbelltown, NSW, Australia., Roncolato F; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Macarthur Cancer Therapy Centre, Campbelltown, NSW, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia., Joshua A; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; St Vincent's Hospital Sydney, Darlinghurst, NSW, Australia., Ferguson T; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Fiona Stanley Hospital, Perth, WA, Australia., Prithviraj P; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Ballarat Oncology and Haematology Services, Ballarat, VIC, Australia., Morris M; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Sunshine Coast University Hospital, Birtinya, QLD, Australia., Harrison M; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Hunters Hill, NSW, Australia., Begbie S; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; North Coast Cancer Institute, Port Macquarie Base Hospital, Port Macquarie, NSW, Australia., Hovey E; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Randwick, Sydney, NSW, Australia.; Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia., George M; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Northwest Cancer Centre, Tamworth Hospital, Tamworth, NSW, Australia., Liow EC; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Monash Health, Melbourne, VIC, Australia., Link EK; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Centre for Biostatistics and Clinical Trials (BaCT), Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, VIC, Australia., McJannett M; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia., Gedye C; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, NSW, Australia.; Calvary Mater Newcastle, Waratah, NSW, Australia.

مؤلفون مشاركون: Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), UNISoN Investigators

المصدر: BJU international [BJU Int] 2024 Feb; Vol. 133 Suppl 3, pp. 57-67. Date of Electronic Publication: 2023 Nov 20.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-410X (Electronic) Linking ISSN: 14644096 NLM ISO Abbreviation: BJU Int Subsets: MEDLINE

مواضيع طبية MeSH: Nivolumab*/therapeutic use , Nivolumab*/adverse effects , Carcinoma, Renal Cell*/drug therapy , Carcinoma, Renal Cell*/pathology, Adult ; Humans ; Ipilimumab/adverse effects ; Disease Progression ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

SCR Disease Name: Clear-cell metastatic renal cell carcinoma

المؤلفون: Blinman, P.L. ^*, Davis, I.D., Martin, A., Troon, S., Sengupta, S., Hovey, E., Coskinas, X., Kaplan, R., Ritchie, A., Meade, A., Eisen, T., Stockler, M.R.

المصدر: In Annals of Oncology February 2018 29(2):370-376

المؤلفون: Halkett, G. K. B.^Aff1, Lobb, E. A.^{Aff2, Aff3}, Shaw, T., Sinclair, M. M., Miller, L.^{Aff5, Aff6}, Hovey, E.^{Aff7, Aff8}, Nowak, A. K.^{Aff9, Aff10}

المصدر: Supportive Care in Cancer. 26(1):275-286

المؤلفون: Bergin, A. R. T., Hovey, E., Lloyd, A., Marx, G., Parente, P., Rapke, T., de Souza, P.

المصدر: Supportive Care in Cancer. September 2017 25(9):2871-2879

المؤلفون: Halkett GKB; Faculty of Health Sciences, Curtin School of Nursing, Curtin University, GPO Box U1987, Bentley, WA, 6005, Australia. g.halkett@curtin.edu.au., Berg MN; Faculty of Health Sciences, Curtin School of Nursing, Curtin University, GPO Box U1987, Bentley, WA, 6005, Australia.; School of Nursing and Midwifery, The University of Notre Dame Australia, Fremantle, WA, Australia., Daudu D; Faculty of Health Sciences, Curtin School of Nursing, Curtin University, GPO Box U1987, Bentley, WA, 6005, Australia.; Medical School, University of Western Australia, Nedlands, WA, Australia., Dhillon HM; Psycho-Oncology Cooperative Research Group, School of Psychology, Faculty of Science, University of Sydney, Camperdown, NSW, Australia.; Centre for Medical Psychology & Evidence-Based Decision-Making, School of Psychology, Faculty of Science, University of Sydney, Camperdown, NSW, Australia., Koh ES; South West Sydney Clinical School, UNSW Medicine, University of New South Wales, Liverpool, NSW, Australia.; Liverpool and Macarthur Cancer Therapy Centres, Liverpool, Australia.; Ingham Institute for Applied Medical Research, Liverpool, Australia., Ownsworth T; School of Applied Psychology & The Hopkins Centre, Menzies Health Institute Queensland, Griffith University, Brisbane, QLD, Australia., Lobb E; Calvary Health Care Kogarah, Sydney, NSW, Australia.; School of Medicine, The University of Notre Dame, Sydney, NSW, Australia.; Faculty of Health, University of Technology, Ultimo, NSW, Australia., Phillips J; Faculty of Health, School of Nursing, Queensland University of Technology, Brisbane, Australia., Langbecker D; Centre for Online Health and Centre for Health Services Research, The University of Queensland, Brisbane, Australia., Agar M; Faculty of Health, University of Technology, Ultimo, NSW, Australia., Hovey E; South West Sydney Clinical School, UNSW Medicine, University of New South Wales, Liverpool, NSW, Australia.; Prince of Wales Clinical School, UNSW Medicine, University of New South Wales, Randwick, Australia.; Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Randwick, Australia., Moorin R; Faculty of Health Sciences, Curtin School of Population Health, Curtin University, Bentley, WA, Australia.; School of Population and Global Health, University of Western Australia, Nedlands, WA, Australia., Nowak AK; Medical School, University of Western Australia, Nedlands, WA, Australia.; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.

المصدر: Journal of neuro-oncology [J Neurooncol] 2022 May; Vol. 157 (3), pp. 475-485. Date of Electronic Publication: 2022 Apr 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE

مواضيع طبية MeSH: Caregivers*/psychology , Glioma*/psychology , Glioma*/therapy, Australia ; Cross-Sectional Studies ; Humans ; Palliative Care

المؤلفون: Alpen K; Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia., Vajdic CM; The Kirby Institute, UNSW Sydney, Sydney, New South Wales 2052, Australia., MacInnis RJ; Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria 3004, Australia., Milne RL; Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria 3004, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia., Koh ES; South Western Sydney Clinical School, Faculty of Medicine, University of New South Wales, Liverpool, New South Wales, Australia.; Liverpool and Macarthur Cancer Therapy Centres, Liverpool Hospital, Liverpool, New South Wales, Australia.; Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia., Hovey E; Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Randwick, Sydney, New South Wales 2031, Australia.; Faculty of Medicine, Prince of Wales Clinical School UNSW, Sydney, New South Wales, 2052, Australia., Harrup R; Royal Hobart Hospital, Hobart, Tasmania, Australia.; University of Tasmania, Hobart, Tasmania, Australia., Bruinsma F; Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria 3004, Australia., Nguyen TL; Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia., Li S; Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3051, Australia., Joseph D; Department of Medicine and Surgery, The University of Western Australia, Perth, Western Australia, Australia., Benke G; School of Public Health and Preventative Medicine, Monash University, Clayton, Victoria, 3004, Australia., Dugué PA; Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria 3004, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia., Southey MC; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria 3004, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.; Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Parkville, Victoria, Australia., Giles GG; Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria 3004, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia., Rosenthal M; The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Drummond KJ; Department of Neurosurgery, Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia.; Department of Surgery, University of Melbourne, Parkville, Victoria, 3050, Australia., Nowak AK; Medical School, University of Western Australia, Crawley, Western Australia 6008, Australia., Hopper JL; Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia., Kapuscinski M; Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia., Makalic E; Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.

المصدر: Neuro-oncology [Neuro Oncol] 2023 Jul 06; Vol. 25 (7), pp. 1355-1365.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Glioma*/genetics , Brain Neoplasms*/genetics , Glioblastoma*/genetics, Female ; Humans ; Adult ; Male ; Genome-Wide Association Study ; Genetic Predisposition to Disease ; Australia ; Polymorphism, Single Nucleotide ; Case-Control Studies ; Nerve Tissue Proteins ; Intracellular Signaling Peptides and Proteins/genetics

المؤلفون: Kong, BY, Carter, C, Nowak, AK, Hovey, E, Lwin, Z, Haghighi, N, Gan, Hui, Sim, HW, Ziegler, DS, Barton, K, Parkinson, J, Leonard, R, Khasraw, M, Foote, M

مصطلحات موضوعية: education, health care economics and organizations, Uncategorized

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::277f036e1829905637f5bd50f6355e8d

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.